In this issue:
Secukinumab therapy does not increase the risk for malignancy
Pregnancy outcomes in patients receiving ixekizumab
The impact of COVID-19 on behaviour and healthcare access
Chronic pain prevalent in all types of axSpA
Secukinumab may cause flare of pre-existing IBD in patients with AS
Ixekizumab improves sleep and work productivity in patients with nr-axSpA
COAST-V/W: Ixekizumab improves PROs in radiographic axSpA
MRI for assessing disease and prediction of relapse in early peripheral SpA
Pain alone does not increase risk for death in PsA
Guselkumab elicits resolution of enthesitis and reduced disease burden in PsA
Clinically meaningful improvement in PROs by upadacitinib for PsA
Please login below to download this issue (PDF)